Related Experiment Video
Updated: Mar 12, 2026

Author Spotlight: Discovering New Alkaloids in Plants with Advanced Mass Spectrometry Techniques
Published on: March 8, 2024
New withanolides with TRAIL-sensitizing effect from Physalis pubescens L
Li-Xia Chen1, Gui-Yang Xia2, Hao He3
1Department of Natural Products Chemistry, School of Traditional Chinese Materia Medica, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China; Department of Urology, University of California, Irvine, Orange, CA 92868, USA.
New withanolide steroids from Physalis pubescens L. show potent anti-cancer activity. Compound 1 effectively inhibits renal cell carcinoma (RCC) growth and induces apoptosis, suggesting its potential for RCC treatment.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Cancer Biology
Background:
- Physalis pubescens L. (husk tomato) is known for nutritious fruits, but its bioactive compounds remain largely uncharacterized.
- Withanolides, a class of steroidal lactones, are known for diverse biological activities.
Purpose of the Study:
- To isolate and characterize novel bioactive compounds from Physalis pubescens L.
- To evaluate the anti-cancer potential of isolated compounds against human renal cell carcinoma (RCC).
Main Methods:
- Isolation and structural elucidation of withanolides using extensive spectroscopic analyses.
- In vitro anti-proliferative assays against four human RCC cell lines.
- Apoptosis induction studies, including Western blotting and molecular docking.
Main Results:
- Four new withanolides (1-4) and one known withanolide (5) were identified.
- Compounds 1, 3, and 5 exhibited significant growth inhibitory effects on RCC cell lines, with compound 1 being the most potent (IC50s 0.30–0.77 μM).
- Compound 1 enhanced TRAIL-induced apoptosis in 786-O RCC cells by upregulating CHOP and DR5, activating the DR5/caspase-8/3 pathway.
Conclusions:
- A novel withanolide (1) from Physalis pubescens L. demonstrates potent anti-cancer activity against renal cell carcinoma.
- Compound 1 acts as a lead compound for potential RCC therapeutics by inducing apoptosis through the TRAIL/DR5 pathway.
- Further investigation of this withanolide is warranted for RCC prevention and treatment strategies.
More Related Videos
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Tonicity in Plants
Tonicity
Tonicity describes the capacity of a cell to lose or gain water depending on the solute...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs that Stabilize Microtubules

